An Evaluation  phase, where we review the patient, not only physically but metabolically and molecularly, and we take special interest in the diagnosis of other conditions, which may alter or accelerate survival.

In addition, patients are evaluated metabolically with basic and specific studies, aimed at understanding the current state of the immune system and the system of oxidation, these specific studies are: Tumor Necrosis Factor, Circulating Tumor Cell Count, (CTC), regulatory T lymphocytes, Glutathione, sensitivity to products of complementary and alternative medicine.